Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）

NCT05512520 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Esophageal Squamous Cell Carcinoma

Interventions

COMBINATION_PRODUCT: Intensity-modulated radiotherapy concurrent with capecitabine

Sponsor

Sun Yat-sen University